|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.040 USD | -0.70% |
|
+13.30% | -51.17% |
| 08-20 | ABVC BioPharma, Inc. completed the Spin-Off of BioKey, Inc. | CI |
| 08-12 | ABVC BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: ABVC BioPharma, Inc.
Delayed Quote Nasdaq
| 2026-10-19 | 2026-10-20 | 2026-10-21 | 2026-10-22 | 2026-10-23 | |
|---|---|---|---|---|---|
| Last | US$0.9100 | US$0.9300 | US$1.000 | US$1.047 | US$1.040 |
| Volume | 26,892 | 11,820 | 49,336 | 45,691 | 22,011 |
| Change | -0.86% | +2.20% | +7.53% | +4.73% | -0.70% |
| Opening | US$0.9180 | US$0.9200 | US$1.000 | US$1.020 | US$1.040 |
| High | US$0.9417 | US$0.9899 | US$1.018 | US$1.068 | US$1.060 |
| Low | US$0.8918 | US$0.9200 | US$0.9600 | US$1.000 | US$1.030 |
Performance
| 1 day | -0.70% | ||
| 1 week | +13.30% | ||
| Current month | -1.89% | ||
| 1 month | -4.59% | ||
| 3 months | -9.57% | ||
| 6 months | -2.80% | ||
| Current year | -51.17% | ||
| 1 year | -65.10% | ||
| 3 years | +16.85% | ||
| 5 years | -95.79% | ||
| 10 years | -99.71% |
Volumes
marketsDaily volume
22,011
Estimated daily volume
22,011
Avg. Volume 20 sessions
64,246
Daily volume ratio
0.34
Avg. Volume 20 sessions USD
66,815.84
Record volume 1
89,146,344
Record volume 2
82,234,139
Record volume 3
33,802,503
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
27,002,388
Net sales (USD)
0
Free-Float
79.73%
Free-Float capitalization (USD)
22,741,009
Average Daily Capital Traded
0.25%
Indicators
Moving average 5 days
0.961
Moving average 20 days
0.9978
Moving average 50 days
0.9744
Moving average 100 days
1.139
Price spread / (MMA5)
-7.60%
Price spread / (MMA20)
-4.06%
Price spread / (MMA50)
-6.31%
Price spread / (MMA100)
+9.53%
RSI 9 days
60.72
RSI 14 days
55.58
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.70% | +13.30% | -65.10% | +16.85% | 27M | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| Average | +0.18% | +3.40% | +36.76% | +128.48% | 38.31B | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.01% | +142.83% |
Historical Quotes: ABVC BioPharma, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
b8e28e78539f6f356dc4ff11.dywWteLTLmt0war5tqghfnQTmviIfa0mWDOsrEs_9pc.GWMj4pWlZzo4pPWfxZlKNyRM_5KxNPtodWLcnDJyotkVf3_f1J1JDAG4mg
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 1.040 | 467 | 12,559 |
| 15:59:58 | 1.040 | 100 | 12,092 |
| 15:59:58 | 1.050 | 1,100 | 11,992 |
| 15:59:22 | 1.047 | 100 | 10,892 |
| 15:57:46 | 1.050 | 102 | 10,792 |
| 15:56:17 | 1.045 | 1,000 | 10,690 |
| 15:45:52 | 1.050 | 601 | 9,690 |
| 15:45:52 | 1.050 | 807 | 9,089 |
| 15:45:52 | 1.045 | 200 | 8,282 |
| 14:02:23 | 1.050 | 102 | 8,082 |
Price Extremes
| 1 week | 0.89 |  | 1.07 |
| 1 month | 0.89 | | 1.14 |
| Current year | 0.71 | | 2.43 |
| 1 year | 0.71 | | 3.06 |
| 3 years | 0.4 | | 5.48 |
| 5 years | 0.4 | | 116.9 |
| 10 years | 0.4 | | 378 |
Monthly variations
Annual variations
| 2026 | -51.17% | ||
| 2025 | +261.02% | ||
| 2024 | -49.14% | ||
| 2023 | -81.44% | ||
| 2022 | -81.56% | ||
| 2021 | -33.53% | ||
| 2020 | +16.70% | ||
| 2019 | -87.86% | ||
| 2018 | 0.00% | ||
| 2017 | 0.00% | ||
| 2016 | -74.87% | ||
| 2015 | +249,900.21% | ||
| 2014 | 0.00% | ||
| 2013 | +88.68% | ||
| 2012 | -94.11% | ||
| 2011 | +80.00% | ||
| 2010 | -79.17% | ||
| 2009 | -65.71% | ||
| 2008 | -77.78% | ||
| 2007 | -10.00% | ||
| 2006 | +131.79% | ||
| 2005 | +277.50% | ||
| 2004 | 0.00% |
- Stock Market
- Stocks
- ABVC Stock
- Quotes ABVC BioPharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
